99.4%
tirzepatidetype 2 diabetesfinerenoneorforglipronGLP-1RAschronic kidney diseaseThe BMJ
…ncluding effects of SGLT-2 inhibitors, GLP-1RAs, finerenone and tirzepatide.Systematic review registration PROSPERO number: CRD42022325948.…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 215 of 2459ARVCTN-401University of California, San Francisco
…GE-1 show positive safety, tolerability and efficacy results in ARVC adults, Tenaya Therapeutics plans to assess TN-401 in a broader…
FexofenadinemidodrineImatinibPOTSprednisolonepropranololorthostatic intolerancelifestyle measuresEhler’s syndrome
…6V genetic mutation resistant to Imatinib. She was treated with Fexofenadine, emergency adrenaline Epipen and intermittent prednisolone. Rep…
DiabeteshypertensionThyroid diseaseheart failurecoronary artery disease (CAD)COPDOSAatrial fibrillationCADDCCV+2 more
… of association with failed DCCV 1- Hypertension 48.7% 0.512 2- Diabetes 15% 0.1 3- Thyroid disease 7.3% 0.28 4- COPD 5.2% 0.73 5- Valvu…
heart failureNT-proBNPischaemic heart diseaseHFpEF
…lds for detection of HF. B) kaplan-meier plots of time to first heart failure hospitalisation or CV death, stratified by 125 pg/ml and indivi…
chronic kidney diseaseAcute Coronary SyndromeNT-proBNPHFanaemiaBSEBritish Society of Echocardiography
…hmia) and non-cardiac (advancing age and co-morbidities such as chronic kidney disease and anaemia). These factors must be taken into account when uti…
DiabetesHaematologyDermatologyCardiologyEpsom & St Helier University Hospitals NHS TrustNephrologyEndocrinologyNHS DigitalA&GA&G
…) 2021 2022 2023 Cardiology 1.7 2.3 3.2 Dermatology 1.5 1.7 2.4 Diabetes & Endocrinology 0.8 1.1 1.4 Haematology 1.7 2.0 2.5 Nephrology …
methylphenidateattention deficit/hyperactivity disorderDrug treatmentADHD
…% female), 84 282 (56.7%) started drug treatment for ADHD, with methylphenidate being the most commonly prescribed at initiation (74 515; 88.4%…
flumazenilpropofolRemimazolam besylateremimazolamCentral South UniversityDESecond Xiangya HospitalIBM Corp.
…mal accumulation, and its sedative effects can be reversed with flumazenil. This study aimed to evaluate the incidence of DE from anaesthe…
TBXpert MTB/RIF UltraTuberculosisTB-LAMTB-LAMP
…PLWH), who face significantly higher risks of developing active TB. Conventional diagnostic methods such as sputum smear microscop…
uTBADiMTTEVARaortic dissection
…iseases-10: I71.0), 4995 met all eligibility criteria for acute uTBAD. Among these patients, 96 underwent TEVAR in the subacute phase…
TNFiIBDinflammatory bowel disease (IBD)rheumatoid arthritisimmune-mediated inflammatory diseases (IMIDs)TNFi-treatedvaccinationTumour necrosis factor inhibitors
…ent for immune-mediated inflammatory diseases (IMIDs). However, TNFi therapy causes a faster waning of antibody responses following …